Boldine is a potent natural antioxidant present in the leaves and bark of the Chilean boldo tree. Here we assessed the protective effects of boldine on endothelium in a range of models of diabetes, ex vivo and in vitro.
Introduction
Type II diabetes, a common metabolic disorder, is characterized by hyperglycaemia and hyperinsulinaemia, which impair the functions of both the macro-and microcirculations, thus increasing the risks of developing hypertension and atherosclerosis (Tranche et al., 2005; Senador et al., 2009) . Excessive oxidative stress or increased production of reactive oxygen species (ROS) damage endothelial function as an early pathological event leading to cardiovascular diseases (Heitzer et al., 2001) . For example, increased formation of NADPH oxidase-dependent superoxide anion has been observed in diabetic animals including db/db mice, dietinduced obese mice, Otsuka Long-Evans Tokishima Fatty (OLETF) rats, and Goto-Kakizaki (GK) rats (Kim et al., 2002; Gupte et al., 2010; Tian et al., 2011) . Activation of angiotensin II AT1 receptors (receptor nomenclature follows Alexander et al., 2011) plays a critical role in mediating endothelial dysfunction through AT1 receptor-dependent NADPHderived ROS overproduction in arteries of db/db diabetic mice (Wong et al., 2010b; Tian et al., 2011) , while Ang II is itself a potent vasoconstrictor with pro-inflammatory, mitogenic and profibrotic properties.
Bone morphogenetic protein (BMP), a member of the TGF-β superfamily, activates Smads as the immediate downstream molecules, following binding to BMP receptors (Chen et al., 2004) . The BMP family comprises several forms including BMP2, BMP4 and BMP7, which are up-regulated in diabetes and act as pro-inflammatory regulators in blood vessels (Nett et al., 2006; Bostrom et al., 2011) . BMP4 impairs endothelial function in mouse aortas either by increased ROS formation through NADPH oxidase or up-regulation of cyclooxygenase-2 (Miriyala et al., 2006; Wong et al., 2010a ). An elevated expression of BMP4 and NAPDH oxidase in db/db mice suggests a positive involvement of this redox-sensitive pro-inflammatory mechanism in diabetes (San Martin et al., 2007) . Therefore, natural products that improve endothelial function in diabetes by favourable modulation of redoxsensitive mechanisms are potentially useful for treating diabetic vasculopathy.
Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) is an alkaloid of the benzylisoquinoline family and found as the major alkaloid in the leaves and bark of the Chilean boldo tree (Peumus boldus Molina; O'Brien et al., 2006) . Boldine exhibits potent antioxidative properties (Cassels et al., 1995) and, although the pharmacological effects of boldine were reported a decade ago, whether this antioxidant activity benefits vascular function in mouse models of type II diabetes, remains to be elucidated. Therefore, the present study investigated the hypothesis that in vivo and in vitro treatment with boldine ameliorates endothelial dysfunction in diabetic db/db mice by inhibiting the Ang II-mediated, BMP4-dependent, oxidative stress cascade.
Methods

Animals and experimental protocol
All animal care and experimental procedures were approved by the CUHK Animal Experimentation Ethics Committee. All studies involving animals are reported in accordance with the ARRIVE guidelines for reporting experiments involving animals McGrath et al., 2010) . A total of 52 animals were used in the experiments described here. Male diabetic mice (C57BL/KSJ background) lacking the gene encoding for leptin receptor (db/db), heterozygote (db/m + ) and non-diabetic C57 mice were purchased from the Laboratory Animal Service Center of Chinese University of Hong Kong (CUHK). Mice were maintained in a well-ventilated holding room at constant temperature of 24 ± 1°C and received normal chow and tap water ad libitum. The db/db mice (16-17 weeks old) were randomly assigned to control (vehicle), boldine or tempol treatment groups, and they were treated daily with vehicle (20% ethanol, 0.8 ml kg −1 ), or boldine (20 mg kg
) or tempol (20 mg kg −1 day −1 ) by oral administration for 7 days. At the end of the treatment period, mice were killed by CO2 inhalation.
Artery preparation
The thoracic aorta was isolated, cleaned of surrounding connective tissues, and cut into several ring segments, each 2 mm in length. Rings were suspended in a Multi Wire Myograph System (Danish Myo Technology, Aarhus, Denmark) and bathed in oxygenated Krebs solution containing (in mmol L −1 ) NaCl 119, NaHCO3 25, KCl 4.7, KH2PO4 1.2, MgSO4.7H2O 1.2, glucose 11.7 and CaCl2.2H2O 2.5. Some arteries were snap-frozen in liquid nitrogen and stored in-80°C for later processing. All rings were maintained at 37°C, stretched to an optimal baseline tension of 3 mN, and continuously oxygenated by 95% O2 and 5% CO2. The changes of isometric tension were recorded by a PowerLab LabChart 6.0 recording system (AD Instruments, Bella Vista, NSW, Australia).
Experimental protocol
After equilibration for 30 min, rings were first contracted by 60 mM KCl and washed in Krebs solution three times before phenylephrine (1 μmol L −1 ) was added to induce a stable contraction. Concentration-response curves for both endothelium-dependent relaxations in response to ACh (3 nmol L −1 to 10 μmol L −1 ) and endothelium-independent relaxations to sodium nitroprusside (SNP, 1 nmol L −1 to 10 μmol L −1 ) were obtained.
Detection of ROS formation in en face endothelium and cryostat sections of mouse aortas
The level of oxidative stress in en face endothelium and cryostat sections of mouse aorta was assessed by confocal microscopy using dihydroethidium (DHE) dye. The aortic segments and cryostat sections (5 μm) of mouse aortas were preincubated in DHE (5 μmol L −1 , Invitrogen, Carlsbad, CA, USA) for 15 min in normal physiological saline solution (NPSS, composition in mmol L −1 : NaCl 140, KCl 5, CaCl2 1, MgCl2 1, glucose 10 and HEPES 5; Tian et al., 2012b) . At the end of incubation, aortic DHE dye was washed away and the fluorescence intensity at one optical section of the rings was visualized using a Olympus FV1000 laser scanning confocal system (Olympus, Tokyo, Japan). The fluorescence intensity was measured with 515 nm excitation and 585 nm emission and the images were analysed using Olympus Fluoview software (version 2.0, Olympus).
Detection of vascular superoxide formation
The amount of superoxide anion formation was determined using the lucigenin-enhanced chemiluminescence method (Lau et al., 2013) . Briefly, isolated mouse aortic rings were pre-incubated for 45 min at 37°C in 2 mL of Krebs-HEPES buffer (in mmol L −1 : NaCl 99.0, NaHCO3 25, KCl 4.7, KH2PO4 1.0, MgSO4 1.2, glucose 11.0, CaCl2 2.5 and Na-HEPES 20.0) in the presence of diethylthiocarbamic acid (1 mmol L −1 ) to inactivate superoxide dismutase (SOD) and β-nicotinamide adenine dinucleotide phosphate (0.1 mmol L −1 ), as substrate for NADPH oxidase. The rings were then transferred into vials containing 300 uL of Krebs-HEPES buffer containing 10 μmol L −1 lucigenin. Repeated measurements were made over 10 min in 1 min intervals using a luminometer (GloMax® 20/20 Luminometer, Madison, WI, USA). The data were expressed as average counts per mg of tissue dry weight.
Detection of AT 1 receptors by immunohistochemical staining
The localization of AT1 receptors in mouse aortas was determined by immunohistochemistry (Wong et al., 2010a) . Briefly, aortic rings were fixed in 4% paraformaldehyde at 4°C overnight and then were dehydrated and embedded in paraffin on the following day. The paraffin block was cut into 5 μm thick sections on microtome (Leica Microsystems, Nussloch, Germany), followed by re-hydration. Sections were then treated with 1.4% H2O2 in absolute methanol for 30 min at room temperature to block the activity of endogenous peroxidase. To avoid false negative staining, sections were boiled in 0.01 mol L −1 sodium citrate buffer (pH 6) for 15 min to unmask antigenic sites in the specimens. After washing in PBS, sections were blocked with 5% donkey serum (Jackson Immunoresearch, West Grove, PA, USA) for 1 h and incubated with primary mouse monoclonal antibody to the AT1 receptor (1: 50, Abcam, Cambridge, UK) overnight in a humidified chamber at 4°C. At the end of incubation period, sections were incubated with biotin-SP conjugated goat antimouse secondary antibodies (1:200, Jackson Immunoresearch) for 1 h at room temperature and then for 30 min with streptavidin-HRP conjugate (1:200, Zymed Laboratory, San Francisco, CA, USA). Sections were washed in PBS three times and colours were developed using 3,3′-diamonobenzidine peroxidase substrate kit (Vector Lab, Burlingame, CA, USA). The nuclei were counterstained with haematoxylin and sections without primary antibody served as negative controls. Images were captured using Leica DMRBE microscope coupled to SPOT-RT cooled CCD colour digital camera and SPOT Advanced software (Version 3.5.5, Diagnostic Instruments, Sterling Heights, MI, USA).
Organ culture of isolated aortas
The isolated aortic rings were cultured in DMEM (Gibco, Gaithersberg, MD, USA) supplemented with 10% FBS (Gibco), 100 U mL −1 penicillin and 100 μg mL −1 streptomycin. Aortas from db/db mice were incubated for 12 h in the presence or absence of boldine (1 μmol L −1 in 0.001% DMSO), tempol (SOD mimetic, 100 μmol L −1 ), noggin (BMP4 antagonist, 100 ng ml ) for 24 h and thereafter transferred to wire myographs for functional examinations.
Primary culture of mouse aortic endothelial cells (MAECs)
Primary MAECs were isolated from two male C57BL/6J mice (5-6 weeks old; Tian et al., 2012a) . In brief, the aorta was isolated from anaesthetized mice after a single intraperitoneal injection of pentobarbital sodium (40 mg kg −1 ) and perfusion of heparin (100 U mL −1 ) through the circulation from the left ventricle. The aortas were dissected in sterile ice-cold PBS to remove adipose and connective tissues and then incubated for 10 min in collagenase type 1A (Sigma, St. Louis, MO, USA) solution at 37°C with gentle shaking. Detached endothelial cells were centrifuged at 800 g for 10 min and the cell pellets were re-suspended and cultured in endothelial cell growth medium (EGM, Gibco, Invitrogen) containing 20% FBS, 100 U mL −1 penicillin and 100 μg mL −1 streptomycin, in addition to endothelial cell growth supplement (50 μg mL −1 , BD Transduction Laboratory, San Diego, CA, USA). The cells were kept in a humidified atmosphere containing 5% CO2 at 37°C for 45 min and culture medium was then replaced and cells allowed to grow into confluence. Cells from passages between 1 and 3 were used for the present study. The endothelial cells were verified by positive staining for PECAM-1 (Santa Cruz, Santa Cruz, CA, USA) and negative staining for the smooth muscle marker, β-actin (DakoCytomation, Carpinteria, CA, USA).
Measurement of intracellular ROS formation in MAECs
Intracellular ROS production in MAECs was measured by a fluorogenic probe, CM-H2DCFDA and the fluorimetric signal was captured on an Olympus FV1000 laser scanning confocal system (Olympus, America Inc.). Briefly, the confluent MAECs were seeded on circular cover slips and incubated in a low serum medium (EGM with 2% FBS) for 4 h. The cells were then exposed to high glucose (30 mmol L 
Western blotting
Aortas and MAECs were homogenized in ice-cold 1X RIPA buffer containing leupeptin 1 μg mL −1 , aprotonin 5 μg mL −1 , PMSF 100 μg mL
, and β-glycerolphosphate 2 mg mL −1 . The lysates were centrifuged at 20 000 g for 20 min and the supernatant was collected for Western blotting. Protein concentrations of the supernatant were determined by a modified Lowry assay (Bio-Rad Laboratories, Hercules, CA, USA). Samples of protein (15μg)
loaded in each lane were separated on 7.5 or 10% SDSpolyacrylamide gel and then transferred to an immobilon-P polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA) at 100 V. The blots were blocked for non-specific binding with 2% BSA or 5% non-fat milk in Tris-buffered saline containing 0.1 % Tween 20 (TBS) for 1 h at room temperature with gentle shaking. After rinsing in TBS-T, the blots were incubated with either primary polyclonal antibody to phosphorylated eNOS at Ser 1177 (p-eNOS-Ser 1177 ; 1:500, Cell Signaling Technology, Inc., Beverly, MA, USA), monoclonal anti-eNOS (1:500, BD Transduction Laboratory), antinitrotyrosine (1:1000, Milipore), anti-AT1 receptor (1:1000, Abcam, Cambridge, UK) or anti-BMP4 (1:500, Sigma). After overnight incubation at 4°C, the membranes were washed three times and incubated with the respective secondary antibodies conjugated to HRP for 2 h at room temperature. The membranes were developed with Amersham TM ECL plus Western blotting detection system (Amersham, Bukinghamshire, UK) and images were captured under ChemiDoc-It® Imaging system (UVP, Cambridge, UK). The densitometric analysis was performed using VisionWorks®LS analysis software and the respective protein expression levels were normalized to the housekeeping proteins β-actin or GAPDH
Data analysis
Results are shown as means ± SEM from n mice. Concentration-response curves were fitted to a sigmoidal curve using non-linear regression with the aid of the statistical software GraphPad Prism version 4 (GraphPad Software Inc., San Diego, CA, USA). Data were analysed for statistical significance using Student's t-test for unpaired observations and, for comparison of more than two groups, one-way ANOVA followed by Bonferroni's multiple comparison test (Prism 5.0, GraphPad Software). A value of P < 0.05 was taken statistically significant.
Materials
ACh chloride, SNP, boldine, L-NAME, phenylephrine, angiotensin II (Ang II) were purchased from Sigma. Tempol was purchased from Tocris (Bristol, UK). Noggin and BMP4 were purchased from R&D System, Inc (Minneapolis, MN, USA). Losartan was purchased from Cayman (Ann Arbor, MI, USA). Noggin and BMP4 were dissolved in PBS plus 0.1% BSA and 4 mmol L −1 HCl respectively. Losartan was dissolved in DMSO. Boldine was dissolved in DMSO for in vitro study or ethanol (20%) for oral feeding. Other drugs were dissolved in double distilled water. Figure 1 shows that the endothelium-dependent relaxations to ACh ( Figure 1A ) but not endothelium-independent relaxations to SNP ( Figure 1B ) also restored the impaired relaxation in these aortas (C). Results are means ± SEM of six separate experiments.
Results
Boldine improves endothelial function in diabetic db/db mice
# P < 0.05 compared with db/m + mice; *P < 0.05 compared with db/db mice.
responses in aortic rings ( Figure 1B) . Such treatment did not affect the plasma lipid profile or glucose levels (data not shown). In addition, treatment with either boldine or tempol restored the decreased phosphorylation of eNOS at Ser 1177 in db/db mouse aortas ( Figure 1C) . Likewise, incubation in vitro with boldine (1 μmol L −1 ) or tempol (100 μmol L −1 ) for 12 h also reversed the impaired ACh-induced relaxations in db/db mouse aortas (Figure 2A & B) , without affecting SNP-induced relaxations ( Figure 2C ). The impaired relaxations were also reversed by treatment with the AT1 receptor antagonist, losartan (3 μmol L −1 ) or the BMP4 antagonist, noggin (100 ng mL −1 ; Figure 2C ).
Boldine reduces vascular oxidative stress in db/db mice
Daily treatment with boldine or tempol for one week normalized the elevated ROS accumulation in en face endothelium ( Figure 3A) , across the vascular wall ( Figure 3B ), and superoxide anion levels ( Figure 3C ) in aortas from db/db mice, as shown by DHE fluorescence, using the lucigenin enhanced-chemiluminescence method. The Western blot results showed that the elevated protein expression of BMP4 ( Figure 4A ) and nitrotyrosine (another oxidative stress index, Figure 4B ) in db/db mouse aortas was reversed by this chronic treatment with boldine or tempol.
Boldine reduces the expression of AT 1 receptors in db/db mouse aortas
Immunohistochemistry staining showed the presence of AT1 receptors in both endothelial cells and smooth muscle cells in mouse aortas and chronic treatment with boldine or tempol reduced the expression of these receptors in the aortas from db/db mice ( Figure 5A ). Such changes were confirmed by the Western blot data ( Figure 5B ).
Table 1
The agonist sensitivity (pEC50) 
Figure 3
Chronic boldine treatment reversed the elevated ROS in en face endothelium (A) and cryostat section of db/db mouse aortas (B) as indicated by changes in DHE fluorescence and inhibited the increased generation of superoxide anion in these aortas (C) as detected by the lucigenin-enhanced chemiluminescence method. Results are means ± SEM of four to six separate experiments.
Boldine protects against Ang II-induced BMP4-dependent endothelial dysfunction
Ang II (500 nmol L −1 ) attenuated the ACh-induced relaxations in aortas from non-diabetic C57 mice ( Figure 6A ) and this impairment was reversed by co-treatment with the BMP4 inhibitor noggin or the AT1 receptor antagonist losartan ( Figure 6B ). Ang II elevated the expression of BMP4 in cultured mouse aortas and this effect was reversed by noggin or losartan ( Figure 6D) . Like noggin or losartan, both boldine and tempol also reversed the impairment of ACh-induced relaxations ( Figure 6C ) and up-regulation of BMP4 expression in Ang II-treated aortas from non-diabetic mice ( Figure 6E ).
Boldine reverses high glucose-induced endothelial dysfunction in mouse aortas
Exposure to high glucose (36 h) attenuated ACh-induced relaxations and this effect was reversed by co-treatment with boldine (1 μmol L −1 ) or tempol (100 μmol L −1 ; Figure 7A ). Treatment with high glucose for 36 h raised the ROS production in MAECs as indicated by changes of the DCF-DA fluorescence intensity, while ROS elevation was prevented by pre-treatment (8 h, data not shown) and co-treatment ( Figure 7B&C ) with boldine or tempol. In addition, high glucose-induced reduction in eNOS phosphorylation in MAECs was reversed by co-treatment with boldine or tempol ( Figure 7D ).
Discussion
The present study provides experimental evidence that in vivo treatment with boldine effectively restored the impaired endothelium-dependent relaxations in aortas of db/db mice and reduced the expression of several oxidative stress markers, BMP4, nitrotyrosine and AT1 receptors in diabetic mouse arteries. The renin-angiotensin system and associated oxidative stress play a crucial role in maintaining endothelial dysfunction in diabetic mice (Wong et al., 2010a) while BMP4 is a novel important mediator of endothelial dysfunction in hypertension (Wong et al., 2010a; Tian et al., 2012b) . To further elucidate the inhibitory effect of boldine on Ang II-mediated vascular dysfunction, Ang II was used to trigger ROS generation and thus reduce the bioavailability of NO in the vascular wall. As expected, treatment with Ang II in vitro impaired the endothelium-dependent relaxations accompanied by raised BMP4 expression in aortas from non-diabetic mice. Co-treatment with boldine reversed the harmful effects of Ang II on relaxations and BMP4 up-regulation. It appears that boldine reduced Ang II-induced BMP expression mainly through limiting ROS generation in the inflamed arteries as the known ROS inhibitor tempol produced the same benefits as boldine. In addition, reducing expression of AT1 receptors and the associated ROS overproduction also played a positive role in the improvement of endothelial function in diabetic db/db mice induced by boldine.
Boldine had been shown to ameliorate the development of diabetes in streptozotocin-treated rats by inhibiting oxidative stress-associated tissue damage and restoring antioxidant enzyme activities (Jang et al., 2000) . We have recently shown that treatment with boldine reversed endothelial dysfunction in hypertensive rats through suppression of NADPH oxidasemediated ROS overproduction (Lau et al., 2012) and protected endothelial function in high glucose-induced oxidative stress through inhibiting the expression of NADPH oxidase (Lau et al., 2013) . In addition, boldine reduced carrageenan-induced guinea pig paw oedema probably through inhibiting the biosynthesis of pro-inflammatory prostaglandins (Backhouse et al., 1994) . However, the effect of boldine on endothelial dysfunction and vascular inflammatory response in type II diabetes remained undefined. The present study provides novel findings on the protective effect of boldine in endothelial cells through the inhibition of Ang II-mediated BMP4 up-regulation and ROS overproduction, under hyperglycaemic conditions.
The renin-angiotensin system and associated NADPH oxidase-derived ROS mediate endothelial dysfunction in the mouse model of type II diabetes through decreasing the bioavailability of NO (Wong et al., 2010b ). The present study shows that the impaired endothelium-dependent relaxations in db/db mouse aortas or in high glucose-treated mouse aortas were reversed by both in vivo and in vitro treatment with boldine or tempol. The improved relaxations were accompanied by restored phosphorylation of eNOS. Further support comes from experiments on cultures of mouse endothelial
Figure 4
Western blotting showing the up-regulation of expression of BMP4 (A) and nitrotyrosine (B) in aortas from db/db mice with and without receiving 1 week treatment with boldine or tempol. Results are means ± SEM of four separate experiments.
cells in which the high glucose-induced reduction in eNOS phosphorylation was reversed by treatment with boldine or tempol in vitro. BMP4, an important matrix cytokine stimulates the expression of adhesion molecules and induces endothelial dysfunction through NADPH oxidase-dependent mechanisms (San Martin et al., 2007) . Up-regulation of BMP4 in db/db mouse aortas may involve ROS-dependent vascular inflammation (San Martin et al., 2007) . The present results demonstrate that endothelial dysfunction in diabetic mice was accompanied by augmented oxidative/nitrosative stress and BMP4 up-regulation. Treatment with boldine restored
Figure 5
One week treatment with boldine or tempol reduced the expression of AT1 receptors (AT1R) in db/db mouse aortas as detected by immunohistochemistry (A) and Western blotting (B). Arrows indicate the endothelial layer of the artery. Results are shown as mean ± SEM of three to four separate experiments.
Figure 6
Ang II-induced impairment of ACh-induced relaxations was reversed by in vitro treatment with boldine (1 μmol L −1
, A & C), tempol (100 μM, A & C), noggin (100 ng ml −1 , A&B) and losartan (3 μmol L −1 , A & B) in aortas from non-diabetic mice. These four inhibitors normalized Ang II-induced increase in BMP4 expression (D & E) . Results are means ± SEM of four to six separate experiments.
# P < 0.05 compared with control; *P < 0.05 compared with Ang II.
the impaired endothelial function in db/db mice and inhibited ROS overproduction and BMP4 up-regulation. Furthermore, the increased expression and activity of the renin-angiotensin system is likely to be associated with up-regulated expression of BMP4 and the latter causes ROS overgeneration, thus impairing endothelial function in diabetes, while boldine protects endothelial function through inhibiting this AT1 receptor-BMP4-ROS axis. In the present study, boldine reversed the Ang II-induced impairment of ACh-induced relaxations and BMP4 over-expression in vitro and in vivo treatment with boldine normalized the increased expression of AT1 receptors in db/db mouse aortas. The harmful effects of Ang II were inhibited by treatment with the AT1 receptor blocker losartan or the BMP4 antagonist noggin, suggesting that the improved endothelial function in db/db mice is probably attributable to boldine-induced inhibition of the Ang II-mediated BMP4 and associated oxidative stress in the vascular wall. A recent study also indicates a pathophysiological role of BMP4 in Ang II-induced cardiomycyte hypertrophy as Ang II stimulates BMP4 expression in cultured cardiac fibroblasts (Sun et al., 2013) . However, the present study cannot discount the possible involvement of other BMP isoforms such as BMP2, BMP6 and BMP7 in oxidative stress and vascular inflammation in diabetic mice, which deserves future investigation.
Taken together, our present results demonstrate that boldine is effective in inhibiting the AT1 receptor-mediated cellular signalling cascade and in ameliorating endothelial dysfunction in diabetic mice. Our findings further suggest a therapeutic potential of boldine-containing medicinal herbs in alleviating diabetic vasculopathy.
Figure 7
In vitro treatment with boldine or tempol reversed high glucose-induced impairment of ACh-induced relaxations in non-diabetic mouse aortas (A) and normalized the elevated ROS production in high glucose ( # P < 0.05 compared with NG; *P < 0.05 compared with HG.
